HUMA
Humacyte Inc
0.5657$
-2.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 68.8% | 64.9% | 73.0% | 69.5% | 20.0% | 34.7% | 45.3% | 37.3% | 45.2% | 58.3% | 57.5% | 67.2% | |
| 66.9% | 62.7% | 71.5% | 67.7% | 17.9% | 32.6% | 38.7% | 27.4% | 21.3% | 43.4% | 43.9% | 57.9% | |
| 66.9% | 62.7% | 71.5% | 67.7% | 17.9% | 32.6% | 38.7% | 27.4% | 21.3% | 43.4% | 43.9% | 57.9% | |
| 0.0% | 0.0% | – | – | – | 0.0% | 0.3% | 0.3% | 1.2% | 0.4% | 0.4% | 0.2% | |
| – | – | – | – | – | 0.0% | 4.9% | 8.0% | 20.1% | 11.7% | 9.0% | 5.1% | |
| 75.2% | 89.4% | 83.8% | 120.5% | 155.5% | 138.2% | 77.8% | 97.1% | 105.2% | 97.3% | 89.5% | 77.4% | |
| 10.1% | 14.4% | 8.7% | 12.8% | 18.2% | 14.5% | 12.3% | 15.2% | 28.0% | 15.8% | 14.6% | 10.8% | |
| 1.7% | 2.0% | 1.7% | 2.0% | 2.5% | 2.1% | 1.8% | 3.8% | 2.9% | 2.1% | 2.2% | 1.1% | |
| 2.0% | 5.1% | 2.1% | 4.3% | 6.0% | 3.3% | 3.4% | 4.8% | 10.5% | 4.6% | 4.6% | 3.0% | |
| 25.0% | 30.1% | – | – | – | – | – | – | – | 30.5% | 32.4% | 26.3% | |
| 24.8% | 10.6% | 16.2% | -20.5% | -55.5% | -38.2% | 22.2% | 2.9% | -5.2% | 2.7% | 10.5% | 22.6% | |
| -342.9% | -419.0% | -352.5% | -452.6% | -579.5% | -497.6% | -397.9% | -493.2% | -767.2% | -624.6% | -673.4% | -565.8% | |
| 69.2% | 80.8% | 67.0% | 86.2% | 104.0% | 85.9% | 81.1% | 112.0% | 173.0% | 135.9% | 179.0% | 169.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.